← All organizations

Geron Corporation

For profitContributed to NMEWebsite ↗

Also known as: GERON | Geron Corporation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Mar 28, 2025

Timeline

1990s

Jan 1, 1990
Geron Corporation— Founded

2020s

Jun 6, 2024
Imetelstat— NDA Organization

Drugs by trial phase (12 distinct, 17 trials)

Phase 3 (1 own, 0 via acquisition)

Imetelstat

Phase 2 (3 own, 0 via acquisition)

Phase 1 (8 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Imetelstat

Recent trials (24)

NCT05937568Lead sponsorN/A—
NCT06247787CollaboratorPhase 1Mar 28, 2025
NCT05583552CollaboratorPhase 2Dec 31, 2022
NCT05371964Lead sponsorPhase 1May 4, 2022
NCT05371964Study directorPhase 1May 4, 2022
NCT04576156Study directorPhase 3Dec 31, 2020
NCT04576156Lead sponsorPhase 3Dec 31, 2020
NCT01916187CollaboratorPhase 1Jul 1, 2013
NCT01265927CollaboratorPhase 1Jan 1, 2011
NCT01243073Lead sponsorPhase 2Dec 1, 2010
NCT01256762Study directorPhase 2Nov 1, 2010
NCT01256762Lead sponsorPhase 2Nov 1, 2010
NCT01242930Study directorPhase 2Nov 1, 2010
NCT01242930Lead sponsorPhase 2Nov 1, 2010
NCT01137968Lead sponsorPhase 2May 1, 2010

Details

Founded: Menlo Park, CA, US Jan 1, 1990
First NDA: Jun 6, 2024
Last known activity: Mar 28, 2025

Designations held

Orphan drug
Fast track